Evidence map›Paper›PMID 41503514›Full record

ReviewJournal of immunology research2026

Neutrophil Plasticity and NETosis in Tumour Microenvironment: Tumour Evolution and Therapy Resistance.

Mojdeh Soltani, Sara Falahi, Mohammad Abbaszadeh, Mark J M Sullman, Hamed Fouladseresht, Nahid Eskandari

Abstract readReview
In one paragraph

Review in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mojdeh SoltaniDepartment of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.ORCID https://orcid.org/0000-0003-2768-7212
Sara FalahiDepartment of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.
Mohammad AbbaszadehDepartment of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.
Mark J M SullmanDepartment of Social Sciences, University of Nicosia, Nicosia, Cyprus, unic.ac.cy.
Hamed FouladsereshtDepartment of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.ORCID https://orcid.org/0000-0002-6130-7191
Nahid EskandariDepartment of Immunology, Isfahan University of Medical Sciences, Isfahan, Iran, mui.ac.ir.ORCID https://orcid.org/0000-0003-1910-9359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) are web-like formations consisting of DNA-histone complexes and associated proteins released from activated neutrophils. While NET formation plays an important role in innate immunity, it is also associated with the pathogenesis of autoimmune disorders such as rheumatoid arthritis, psoriasis and systemic lupus erythematosus. Research suggests that NETosis (the process of NET formation) may contribute to the progression of cancer and the spread of malignant tumours. A clear link exists between the accumulation of neutrophils in the tumour microenvironment (TME), known as tumour-associated neutrophils (TANs) and NETosis activation in both primary and metastatic tumours. Furthermore, the literature highlights the role of NETs in modulating immune surveillance within the TME. This review aims to analyse the interplay between NETosis and the TME, emphasising its implications for tumour progression, immune evasion and resistance to therapy.

Indexed as

Cell PlasticityExtracellular TrapsNeoplasmsNeutrophilsTumor MicroenvironmentAnimalsDisease ProgressionDrug Resistance, NeoplasmHumansImmunity, InnateImmunotherapyTumor EscapeimmunotherapyNETosisneutrophiltumour microenvironment

Identifiers

PMID41503514
PMCPMC12771616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.